STRUCTURE THERAPEUTICS
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases... with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.
STRUCTURE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Product Research
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.structuretx.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.05 B USD
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset Pound Sterling CrUX Top 5m MediaElement.js
Similar Organizations
BetaGlue Technologies
BetaGlue Technologies engages in research and offers anti-cancer products.
Blueprint Medicines
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Bristol Myers Squibb
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Codetta Biosciences
Codetta Biosciences is a company developing quantitative & digital spatial platform for nucleic acid & protein assays.
Rapt Therapeutics
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a drugmaker company.
Joyo Pharma
Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Productboard
Productboard is a product management system that helps organizations get the right products to market faster.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sage Partners
Sage Partners investment in Series B - Structure Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Structure Therapeutics
Woodline Partners
Woodline Partners investment in Series B - Structure Therapeutics
TF Capital
TF Capital investment in Series B - Structure Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Structure Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Structure Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Structure Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Structure Therapeutics
TCG Crossover
TCG Crossover investment in Series B - Structure Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series B - Structure Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-21 | ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer |
Official Site Inspections
http://www.structuretx.com Semrush global rank: 1.33 M Semrush visits lastest month: 20 K
- Host name: 255.65.174.34.bc.googleusercontent.com
- IP address: 34.174.65.255
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Structure Therapeutics"
About Us | Structure Therapeutics
Jun 16, 2022 DRUG DISCOVERY EXPERTISE. Harnessing structure-based drug design, coupled with our advanced computational technologies and world-class expertise, we are …See details»
Careers | Structure Therapeutics
As individuals and as an organization, we represent ourselves with pride and engage our patient communities with tremendous respect. Innovation. The world of pharma is an ever-expanding, ever-changing environment that presents …See details»
Structure Therapeutics - Crunchbase Company Profile …
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform …See details»
Structure Therapeutics | LinkedIn
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational ...See details»
Structure Therapeutics Strengthens Executive Team with
Sep 17, 2024 In addition, we are building our organization to advance our promising oral amylin compound into the clinic as soon as possible,” said Raymond Stevens, Ph.D., Founder and …See details»
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of …
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral …See details»
Structure Therapeutics Reports Second Quarter 2023 Financial …
Aug 10, 2023 Love brings more than 30 years of experience in the biopharmaceuticals industry and currently chairs the Biotechnology Innovation Organization (BIO) Board. Second Quarter …See details»
Structure Therapeutics Appoints Industry Leaders Eric Dobmeier …
Jan 18, 2023 The company is currently focused on the GPCR family of drug targets. For more information, visit www.structuretx.com and follow the company on Twitter @StructureTx and …See details»
Corporate Presentation - Structure Therapeutics
(For Glycemic Control) 1. No head-to-head study has been conducted evaluating the GSBR-1290 against other product candidates . included herein. Differences exist between study designs …See details»
Structure Therapeutics CEO Raymond Stevens Named to …
Sep 6, 2022 For more information, visit www.structuretx.com and follow the company on Twitter @StructureTx and LinkedIn. About PharmaVoice PharmaVoice is a leading industry …See details»
Structure Therapeutics Announces Positive Results from Phase 1b ...
Sep 29, 2023 GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight loss at 28 days …See details»
Structure Therapeutics Announces Participation in Upcoming …
SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral …See details»
Technology | Structure Therapeutics
GPCRs are key to human health. Yang Yue, Lier Liu, Li-Jie Wu, Yiran Wu, Ling Wang, Fei Li, Junlin Liu, Gye-Won Han, Bo Chen, Xi Lin, Rebecca L Brouillette, Émile Breault, Jean-Michel …See details»
Structure Therapeutics Reports Positive Topline Data from its …
Jun 3, 2024 For additional information, please visit www.structuretx.com. Forward Looking Statements This press release contains “forward-looking statements” within the meaning of the …See details»
News | Structure Therapeutics
Jun 16, 2022 Catch up on our latest press releases, corporate updates and announcements.See details»
What Is a Matrix Organization? Process, Benefits, & Examples
May 1, 2024 What big companies have a matrix organization? A matrix organization is very common in large companies operating on a global scale. Notable examples are Nike, Coca …See details»
Structure Therapeutics to Participate in the Jefferies London ...
SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral …See details»
Presentations | Structure Therapeutics
GSBR-1290 Phase 2 ACCESS Program (November 2024) 761.5 KB Structure Therapeutics GSBR-1290 Obesity Data (June 2024) 1 MB Print PageSee details»
Pipeline | Structure Therapeutics
Yang Yue, Lier Liu, Li-Jie Wu, Yiran Wu, Ling Wang, Fei Li, Junlin Liu, Gye-Won Han, Bo Chen, Xi Lin, Rebecca L Brouillette, Émile Breault, Jean-Michel Longpré, Songting Shi, Hui Lei, …See details»